# RaNA Therapeutics, Inc. — Form D

RaNA Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-11-30. The offering totals $20.7M, of which $2.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2011-11-30
- Form: D
- Accession: 0001535803-11-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $20.7M
- Amount sold: $2.7M
- Remaining: $18.0M
- Investors: 4
- Date of first sale: 2011-11-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-169407

## Issuer

- Name: RaNA Therapeutics, Inc.
- CIK: 0001535803
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 25 FIRST STREET, SUITE 303, CAMBRIDGE, MA, 02141
- Phone: 617-588-2600

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Jean Francois Formela | Director | Cambridge, MA |
| Brian Francois Gallagher | Director | Cambridge, MA |
| Arthur M Krieg | Director | CAMBRIDGE, MA |
| Ankit S Mahadevia | Director | Cambridge, MA |
| Steve S Padgette | Director | Cambridge, MA |
| Mitchell S Bloom | Executive Officer | New York, NY |
| Arthur M Krieg | Executive Officer | CAMBRIDGE, MA |

## More

- [CIK 1535803 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1535803&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001535803-11-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.